Live from the NIH registry
Studies recruiting near Lincoln right now
Top 25 of 160 recruiting studies, sorted by proximity — each links to its official registry page
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Physician Research Collaboration — Lincoln, Nebraska (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Amgen
Abbott Vascular Medical Device Registry
Acute Myocardial Infarction, Restenoses, Coronary
N/A
Observational 3,784 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Abbott Medical Devices
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Paradigm Health
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Jazz Pharmaceuticals
Healthy Children, Healthy Communities: Effectiveness of a Multilevel Rural Community Engagement Model for Improving Children's Dietary Intake in Family Child Care Homes
Childhood Obesity Pevention, Diet Quality
N/A
Interventional 360 participants sought
University of Nebraska Lincoln — Lincoln, Nebraska (0.9 mi)
· Sponsor: University of Nebraska Lincoln
Investigating the Effects of Beef Consumption on Cognitive and Brain Health
Dietary Intervention, Dietary Proteins
N/A
Interventional 240 participants sought
University of Nebraska-Lincoln — Lincoln, Nebraska (0.9 mi)
· Sponsor: University of Nebraska Lincoln
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Phase 3
Interventional 500 participants sought
NHO Revive Research Institute, LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Allergy Asthma & Immunology- Site Number : 8400044 — Lincoln, Nebraska (0.9 mi)
· Sponsor: Sanofi
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Clonal Mast Cell Disease, KIT D816V Mutation
N/A
Observational 750 participants sought
Somnos Clinical Research — Lincoln, Nebraska (0.9 mi)
· Sponsor: Blueprint Medicines Corporation
A Study of V132 in Healthy Older Participants (V132-001)
Healthy
Phase 1
Interventional 280 participants sought
Velocity Clinical Research Lincoln ( Site 0007) — Lincoln, Nebraska (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Phase 3
Interventional 621 participants sought
Nebraska Hematology-Oncology (NHO) — Lincoln, Nebraska (0.9 mi)
· Sponsor: BioNTech SE
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Phase 3
Interventional 600 participants sought
Alivation Research, LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: AstraZeneca
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
Pneumococcal Disease
Phase 3
Interventional 1,200 participants sought
Midwest Children's Health Research Institute — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: DalCor Pharmaceuticals
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: AstraZeneca
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 714 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Non-small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 400 participants sought
Research Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: AstraZeneca
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
Sexual Assault
N/A
Interventional 1,920 participants sought
University of Nebraska - Lincoln — Lincoln, Nebraska (0.9 mi)
· Sponsor: University of Maryland, College Park
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: SWOG Cancer Research Network
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: NRG Oncology
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Non-small Cell Lung Cancer
Phase 3
Interventional 868 participants sought
NHO Revive Research Institute, LLC ( Site 4009) — Lincoln, Nebraska (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC